Abstract
Barrett’s esophagus (BE) results from repeated damage of the esophageal squamous epithelium from gastroesophageal reflux. The defining lesion of BE is specialized intestinal epithelium which is characterized by columnar metaplastic epithelium with goblet cells. BE is a premalignant lesion that progresses to adenocarcinoma at a rate of 0.5% per year. This risk of progression increases with increasing degrees of dysplasia. High-grade dysplasia (HGD) carries the highest risk of developing esophageal adenocarcinoma (EAC) that is 60–125 times that of nondysplastic BE.
The current standard of care for BE with nonvisible HGD is endoscopic ablation. Radiofrequency ablation (RFA) has been found to be safe and effective for the treatment of HGD and can be used in combination with endoscopic mucosal resection for the treatment of superficial (Tis or intramucosal carcinoma and T1a or tumor invade the lamina propria or muscularis mucosae but does not invade the submucosa) EAC. In these clinical settings, the risk of lymph node involvement is low (<4%); thus, localized therapy is effective and can spare patients the morbidity (30%) and mortality (1–2%) of an esophagectomy.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSelected References
Barbour AP, Jones M, Brown I, et al. Risk stratification for early esophageal adenocarcinoma: analysis of lymphatic spread and prognostic factors. Ann Surg Oncol. 2010;17: 2494–502.
Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Tritti A, editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2009.
Fernando HC, Murthy SC, Hofstetter W, et al. The society of thoracic surgeons practice guideline series: guidelines for the management of barrett’s esophagus with high-grade dysplasia. Ann Thorac Surg. 2009;87:1993–2002.
Fleischer DE, Odze R, Overholt BF, et al. The case for endoscopic treatment of non-dysplastic and low-grade dysplastic barrett’s esophagus. Dig Dis Sci. 2010a;55: 1918–31.
Fleischer DE, Overholt BF, Sharma VK, et al. Endoscopic radiofrequency ablation for barrett’s esophagus: 5-year outcomes from a prospective multicenter trial. Endoscopy. 2010b;42:781–9.
Gondrie JJ, Pouw RE, Sondermeijer CM, et al. Effective treatment of early barrett’s neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy. 2008a;40:370–9.
Lyday WD, Corbett FS, Kuperman DA, et al. Radiofrequency ablation of barrett’s esophagus: outcomes of 429 patients from a multicenter community practice registry. Endoscopy. 2010;42:272–8.
Pouw RE, Sharma VK, Bergman JJ, Fleischer DE. Radiofrequency ablation for total barrett’s eradication: a description of the endoscopic technique, its clinical results and future prospects. Endoscopy. 2008;40:1033–40.
Pouw RE, Wirths K, Eisendrath P, et al. Efficacy of radiofrequency ablation combined with endoscopic resection for barrett’s esophagus with early neoplasia. Clin Gastroenterol Hepatol. 2010;8:23–9.
Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in barrett’s esophagus with dysplasia. N Engl J Med. 2009;360:2277–88.
Sharma VK, Wang KK, Overholt BF, et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of barrett’s esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc. 2007;65:185–95.
Stein HJ, Feith M, Bruecher BL, Naehrig J, Sarbia M, Siewert JR. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg. 2005;242:566–73.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Gilbert, E.W., Hunter, J.G. (2012). 18. Endoscopic Ablative Therapy. In: Nguyen, N., Scott-Conner, C. (eds) The SAGES Manual. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-2347-8_18
Download citation
DOI: https://doi.org/10.1007/978-1-4614-2347-8_18
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-2346-1
Online ISBN: 978-1-4614-2347-8
eBook Packages: MedicineMedicine (R0)